FBXW12, a member of the F-box protein family, stands as a pivotal player in cellular regulatory networks, particularly as a critical component of the Skp1-Cullin1-F-box (SCF) E3 ubiquitin ligase complex. The primary function of FBXW12 lies in its role as a substrate recognition module within this complex, orchestrating the targeted degradation of specific proteins through the ubiquitin-proteasome system. This ubiquitin-mediated protein degradation is a fundamental cellular mechanism for maintaining homeostasis, regulating the abundance of proteins crucial for diverse cellular processes. FBXW12, with its F-box domain, interacts with Skp1 and Cul1 to form the SCF complex, conferring specificity to substrate recognition. Its substrate specificity is determined by the interaction of the F-box domain with phosphorylated residues on target proteins, marking them for ubiquitination and subsequent degradation. The intricacies of FBXW12-mediated protein degradation extend to its involvement in various cellular processes, including cell cycle progression, DNA damage response, and signal transduction pathways. By selectively targeting proteins involved in these processes, FBXW12 exerts control over the timing and intensity of cellular responses to internal and external cues. The modulation of FBXW12 activity becomes crucial in instances where aberrant protein turnover may contribute to pathological conditions. Consequently, understanding the mechanisms governing FBXW12 function and its inhibition becomes paramount for unraveling the complexity of cellular regulatory networks.
Inhibition of FBXW12 involves targeted disruptions aimed at impeding its role in substrate recognition and subsequent ubiquitination. Chemical inhibitors strategically intervene at different points in the regulatory network governing FBXW12. For instance, inhibitors like MLN4924 disrupt the NEDDylation pathway, indirectly inhibiting FBXW12 by preventing the modification of substrates critical for its recognition. Proteasome inhibitors, such as MG-132, interfere with the downstream degradation process by blocking the proteasomal machinery, resulting in the accumulation of FBXW12 substrates. Moreover, compounds like JQ1, a bromodomain and extraterminal (BET) protein inhibitor, modulate chromatin accessibility, influencing the transcriptional regulation of genes involved in the control of FBXW12 expression. These diverse mechanisms of inhibition emphasize the complexity of cellular regulatory networks and highlight FBXW12 as a crucial node in the dynamic interplay between protein degradation, signal transduction, and cellular homeostasis.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
BET bromodomain inhibitor. Alters chromatin structure and indirectly influences FBXW12 by impacting the transcriptional regulation of genes involved in the control of its expression, providing an indirect avenue for modulating FBXW12 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor hindering the PI3K/AKT pathway. Modulates intracellular signaling cascades affecting FBXW12 indirectly through altered AKT-dependent processes. |